Precision medicine in systemic lupus erythematosus

S Fasano, A Milone, GF Nicoletti, DA Isenberg… - Nature Reviews …, 2023 - nature.com
Systemic lupus erythematosus (SLE) is an autoimmune disease that has diverse clinical
manifestations, ranging from restricted cutaneous involvement to life-threatening systemic …

[HTML][HTML] Virgin olive oil and health: summary of the III international conference on virgin olive oil and health consensus report, JAEN (Spain) 2018

JJ Gaforio, F Visioli, C Alarcón-de-la-Lastra… - Nutrients, 2019 - mdpi.com
The Mediterranean diet is considered as the foremost dietary regimen and its adoption is
associated with the prevention of degenerative diseases and an extended longevity. The …

Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity

RM Talaat, SF Mohamed, IH Bassyouni, AA Raouf - Cytokine, 2015 - Elsevier
Aim Imbalance of T-helper-cell (TH) subsets (TH1/TH2/TH17) and regulatory T-cells (Tregs)
is suggested to contribute to the pathogenesis of Systemic lupus erythematosus (SLE) …

Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers

H Jeltsch-David, S Muller - Nature Reviews Neurology, 2014 - nature.com
Systemic lupus erythematosus (SLE) is a complex clinical syndrome, elements of which
remain poorly understood. Although recognized over 140 years ago when Kaposi recorded …

Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications

J Liu, X Zhang, X Cao - Journal of autoimmunity, 2022 - Elsevier
Systemic lupus erythematosus (SLE) is a severe chronic systemic autoimmune disease
caused by complicated interactions among genetic, epigenetic, and immunological factors …

Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage …

GG Illei, Y Shirota, CH Yarboro… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To assess the safety of interleukin‐6 receptor inhibition and to collect preliminary
data on the clinical and immunologic efficacy of tocilizumab in patients with systemic lupus …

The diagnosis and clinical management of the neuropsychiatric manifestations of lupus

M Govoni, A Bortoluzzi, M Padovan, E Silvagni… - Journal of …, 2016 - Elsevier
Neuropsychiatric (NP) involvement in Systemic Lupus Erythematosus (SLE), can be a
severe and troubling manifestation of the disease that heavily impacts patient's health …

Interleukin-10 from CD4+ follicular regulatory T cells promotes the germinal center response

BJ Laidlaw, Y Lu, RA Amezquita, JS Weinstein… - Science …, 2017 - science.org
CD4+ follicular regulatory T (Tfr) cells suppress B cell responses through modulation of
follicular helper T (Tfh) cells and germinal center (GC) development. We found that Tfr cells …

[HTML][HTML] Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors

M Figueiredo-Braga, C Cornaby, A Cortez… - Medicine, 2018 - journals.lww.com
Depression and anxiety cause severe loss of quality of life for patients with systemic lupus
erythematosus. The causes and factors that contribute to these psychological manifestations …

Cytokines: names and numbers you should care about

SR Holdsworth, PY Gan - Clinical journal of the American Society …, 2015 - journals.lww.com
Cytokines play an important role in host defense against microorganisms. They orchestrate
innate immunity by inducing protective local inflammation and systemic acute phase …